Risks [qlco]
Hyperparathyroidism, Secondary [dsyn]
chronic [tmco]
Renal [bpoc]
Failure [ftcn]
New [tmco]
Approach [spco]
Review [inpr]
Hyperparathyroidism, Secondary [dsyn]
Common [qnco]
Renal Failure, Chronic [dsyn]
Associated [qlco]
Clinical [qlco]
Risks [qlco]
Including [ftcn]
Risks [qlco]
Renal bone disease [dsyn]
Cardiovascular disease [dsyn]
Death [orgf]
Frequently [tmco]
Neurotoxicity [inpo]
endocrinopathies [dsyn]
Hormone replacement therapy [topp]
Vitamin D Analog [vita]
Excellent [qlco]
Approach [spco]
Diverse [qlco]
Risks [qlco]
Recently [tmco]
Clinical [qlco]
Vitamin D [orch, phsu, vita]
low [qlco]
Therapeutic Index [qnco]
Available [ftcn]
Products [enty]
New [tmco]
Vitamin D Analog [vita]
paricalcitol [orch, phsu, vita]
Doxercalciferol [phsu, strd, vita]
Approved [qlco]
nephrologists [prog]
Calcitriol [horm, phsu, strd, vita]
Deficiency [ftcn]
Risks [qlco]
Safety [hcpp]
Hormone replacement therapy [topp]
New [tmco]
Vitamin D Analog [vita]
Provide [acty]
Renal [bpoc]
Patients [podg]
Physiologic [ftcn]
Levels [qlco]
Active Vitamin D [lbpr]
Metabolites [bacs]
Approximate [qlco]
Normal [qlco]
health state [fndg]
Doxercalciferol [phsu, strd, vita]
Potential [qlco]
Vitamin D [orch, phsu, vita]
Hormone replacement therapy [topp]
Controlled release [tmco]
Approach [spco]
More [ftcn]
mimics [topp]
Normal [qlco]
Physiologic [ftcn]
State [geoa]
